Pyrrolidone-carboxylate peptidase
Pyrrolidone-carboxylate peptidase (PCP), also known as pyroglutamyl-peptidase I, is an enzyme that in humans is encoded by the PGP gene. This enzyme plays a crucial role in the metabolism of proteins by catalyzing the cleavage of pyroglutamyl (pyrrolidone carboxylic acid) residues from the N-terminal end of peptides and proteins. Pyrrolidone-carboxylate peptidase is involved in various biological processes, including protein maturation and degradation, and is essential for the proper functioning of cellular mechanisms.
Function[edit | edit source]
Pyrrolidone-carboxylate peptidase is a hydrolase enzyme that specifically removes pyroglutamic acid from the N-terminus of peptides and proteins, which is a modification occurring post-translationally in many proteins. This enzymatic activity is vital for the maturation and degradation of many peptides and proteins, influencing their stability, activity, and turnover. The removal of the pyroglutamic residue is often a prerequisite for the biological activity of many peptides, including hormones and neuropeptides, thereby playing a significant role in regulating physiological functions.
Structure[edit | edit source]
The structure of pyrrolidone-carboxylate peptidase has been studied in various organisms, revealing a conserved mechanism of action. The enzyme typically operates as a dimer or tetramer and possesses a catalytic triad characteristic of cysteine proteases. The active site of PCP is well adapted for recognizing and binding the pyroglutamic residue, facilitating its efficient cleavage from substrates.
Clinical Significance[edit | edit source]
Alterations in the activity or expression of pyrrolidone-carboxylate peptidase have been implicated in several diseases. Due to its role in processing bioactive peptides, dysregulation of PCP activity can affect numerous physiological pathways, potentially leading to pathological conditions. However, the specific diseases associated with PCP dysfunction are still under investigation, highlighting the need for further research in this area.
Genetic[edit | edit source]
The PGP gene encodes the pyrrolidone-carboxylate peptidase enzyme in humans. Variations in this gene may influence the enzyme's expression or activity, thereby affecting protein processing and degradation pathways. Understanding the genetic aspects of PCP can provide insights into its role in health and disease, offering potential targets for therapeutic intervention.
See Also[edit | edit source]
Pyrrolidone-carboxylate peptidase Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD